Skip to content
S

Suryakant Nagtilak

Publications (3)

Study of Glutathione-s-transferase and Reduced Glutathione Receiving Chemotherapy

Ranjit S. Ambad, Suryakant Nagtilak, Rakesh Kumar Jha & Meghali Kaple · Journal of Pharmaceutical Research International · 2021

Cervical cancer is the third most prevalent cancer in women worldwide, and the fourth leading cause of death from cancer in women. Recent advances, such as the availability of broad scale genome data, articulated gene tag (EST) data bases, innovative sequence alignment techniques...

Open access Research Article 10.9734/jpri/2021/v33i39A32151

Glutathione-S-Transferase Pi and Malondialdehyde in Alcoholic Patients Attending Smhrc and Avbrh Hospital

Ranjit S. Ambad, Suryakant Nagtilak, Gangaram Bhadarge & Meghali Kaple · Journal of Pharmaceutical Research International · 2021

Introduction: Alcohol abuse is a global health problem. The liver maintains high muscle damage by over drinking because it is a major source of ethanol metabolism. Among substance abusers, about 35 % develop advanced liver disease because the number of viral mutations increases,...

Open access Research Article 10.9734/jpri/2021/v33i37A31975

Study of Glutathione S Transferases and Malondialdehyde Levels in Male Smokers from Vidharbha Region, India

Ranjit S. Ambad, Suryakant Nagtilak, Ankita Kondalkar & Ashish Anjankar · Journal of Pharmaceutical Research International · 2021

Introduction: Free radicals are compounds having two unpaired electrons. Free radicals oxidize macromolecule in the body, including proteins, nucleic acids, and lipids. The body uses antioxidants to fight free radicals. Antioxidants may come from the diet or be generated internal...

Open access Research Article 10.9734/jpri/2021/v33i36B31964